Trial Accelerator News Today

Global cancer trial investigator sites have increased 50% in just five years but led to a rise in the number of poorly performing sites, new research ha...

Clinical trial sites for cancer are proliferating, but a lack of investigators with experience in trial recruitment is weighing on their performance.

Global oncology trial investigator sites increase by half in five years, finds new Phesi analysis

Phesi’s artificial intelligence (AI) driven platform, Trial Accelerator, has reached a milestone and now contains global data from more than 100 million patients.

Phesi’s artificial intelligence (AI) driven platform, Trial Accelerator, has reached a milestone and now contains global data from more than 100 million patients.

Phesi releases 2023 analysis of clinical development; breast cancer remains most studied disease area for third year

Excessive costs cost and time to market in clinical trials could soon be eliminated thanks to the addition of a patient access store (PAS) to Phesi's trial accelerator platform.

A partnership has been formed between Phesi and Krsytelis, born out of a need to address the lack of diversity in clinical trials.

Ancora Heart announced that it entered into a strategic partnership with Egnite to accelerate clinical trial enrollment.

A round-up of the latest news from the Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Device sectors from 17th-21st October 2022 ...